| Report ID | 278295 |
| Drug Identification Number | 02239718 |
| Brand name | NEURONTIN |
| Common or Proper name | GABAPENTIN |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | GABAPENTIN |
| Strength(s) | 800MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100BT CA |
| Anatomical Therapeutical Chemical (ATC) code | N02BF |
| Anatomical Therapeutical Chemical (ATC) description | |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2026-01-05 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-02-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-02-18 | French | Compare |
| v1 | 2026-02-18 | English | Compare |
Showing 1 to 2 of 2